Author

Panagiotis Zangas

Institut für Schlaganfall- und DemenzforschungORCID 0009-0006-1350-4154Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:Bayesian inference· 1 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1 Research Focus:GWAS / association mapping· 1 Assay:GWAS summary statistics· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Lanyue ZhangiD· 1 shared Marios K. GeorgakisiD· 1 shared Murad OmaroviD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

3 top collaborators · 3 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Lanyue ZhangORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintMar 9, 2026

✦ In-depth digest

Genetically proxied inhibition of angiotensinogen synthesis is associated with lower cardiovascular risk

Panagiotis Zangas, Murad Omarov, Lanyue Zhang, Marios K. Georgakis

AGT variants mimicking hepatic angiotensinogen synthesis inhibition are linked, via drug-target Mendelian randomization, to lower coronary artery disease, stroke and heart failure risk and higher potassium.

DOI 10.64898/2026.03.08.26347887

humanGWAS summary statistics

𝕏 PostBluesky